Community Health Systems (CYH) Proxy filing summary

Executive summary

• Net operating revenues for 2025 were $12.485 billion, a 1.2% decrease from 2024, but same-store net revenues increased 4.6% year-over-year, with improved admissions and adjusted admissions.

• The company achieved $509 million in net income attributable to stockholders, a significant turnaround from a $516 million loss in 2024.

• Operational highlights included successful debt reduction initiatives, expansion of access points, and improvements in quality and safety metrics at several hospitals.

• Positive free cash flow in 2025 enabled further debt reduction and future capital investments.

Voting matters and shareholder proposals

• Shareholders will vote on electing 14 directors for one-year terms, an advisory vote on executive compensation, and ratification of Deloitte & Touche LLP as the independent auditor for 2026.

• Proxy access and advance notice provisions allow shareholders to nominate directors and submit proposals for future meetings.

Board of directors and corporate governance

• The board consists of 14 nominees with diverse backgrounds in healthcare, finance, academia, and public policy.

• Independent directors comprise a super-majority, and all board committees are fully independent.

• The roles of Board Chair and CEO are separated, and there is a robust Lead Director role.

• Annual board and committee self-evaluations, equity ownership guidelines, and a comprehensive code of conduct are in place.

• Six board members are diverse by gender or race/ethnicity.